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Interaction of Alkylmercuric Compounds
with Sodium Selenite II. Metabolism of
Methylmercuric Chloride Administered
Alone and in Combination with Sodium
Selenite in Rats
by Elzbieta A. Brzeznicka* and Jadwiga Chmielnicka*
Repeated doses of sodium selenite (Se) were administered to rats receiving repeated (IV or PO) doses
of 0.25 or 2.5 mg Hg/kg methylmercuric chloride (Me2"'Hg).
Se (0.5 mg/kg) was observed to alter the distribution of Me2'Hg among tissues as well as among sub-
cellular fractions ofkidneys and liver. An excess ofselenium resulted in atwofold decrease in the mercury
content of kidneys and a similar increase in the mercury content of brain.
Introduction
The problems of toxicity, uptake, distribution and
excretion ofmethylmercury in humans and experimen-
tal animals have been dealt with by many authors and
presented in numerous reports (1-5) monographs (6-
15), and current communications (16-20). However, most
reports have concentrated on specific aspects of these
problems. Complex studies considering dose-dependent
retention, excretion, distribution (organ and subcellu-
lar) and binding ofmethylmercuric chloride to cell com-
ponents depending on the dose and route of
administration ofmethylmercury are lacking.
Although clinical symptoms oftoxicity ofmethymer-
curic compounds are well known (2), trials oftreatment
or amelioration of its toxic effects are still in the ex-
perimental stage.
It has been established that interaction of selenium
with inorganic mercury results in a decreased uptake
of mercury at the site of its administration and de-
creases its excretion with urine and feces. The concen-
trations ofmercury in the liver and blood are significantly
enhanced, but simultaneously the mercury content of
the kidney is significantly reduced (21-24). These
changes are most pronounced when mercury and selen-
ium are administered at at least equimolar doses (21-
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25). The sequence of administration of both these ele-
ments is also important. The effect of selenium on the
distribution ofmercury is smaller when the selenium is
administered after mercury than in the case of simul-
taneous exposure to both these metals (26,27).
The protective action of sodium selenite against the
nephrotoxic effect ofinorganic mercury (13,28-34) and
the beneficial action ofselenium in methylmercury poi-
soninghasbeen described bymany authors (33,35-47).
Sodium selenite administration results in delayed oc-
currence of symptoms of neurological and histological
disturbances andinenhanced lifeexpectancyofexposed
animals (40,43,48).
Results of studies on the selenium-methylmercury
interaction are sometimes contradictory. Selenium has
beenreported toincreasewhole-bodyretentionofmeth-
ylmercury (35), increase levels of methylmercury in
brain, liver, blood, and spleen while reducing the mer-
cury content at kidneys. The effect on brain, noted by
many investigators (41,49-51), is ofspecial interest, since
no symptoms of intoxication were observed in animals
receiving sodium selenite simultaneously with methyl-
mercury, even though the concentration ofmethylmer-
cury in their brain exceeded critical values (13,15). In
other studies simultaneous administration of selenium
was reported to result in significant changes in the dis-
tribution ofmethylmercury in the body (34,41,45). There
are also reports stating that if selenium affects the
methylmercury concentration in the blood at all, it re-BRZEZNICKA AND CHMIELNICKA
sults in a decrease rather than an increase (52) and that
this effectisattributable to aselenium-induced decrease
in the affinity ofred blood cells for methylmercury (52).
These discrepancies prompted the present study of
the effect of selenium on excretion, whole-body reten-
tion, and organ and subcellular distribution and binding
of selenium to proteins of the soluble fraction of the
liver and kidneys. An effort has been made to relate
theresults todose and route ofmethylmercuric chloride
administration in rats.
Materials and Methods
Female Wistar rats, bodyweight 150-200 g, fed stan-
dard LSM diet and allowed to drink tap water ad li-
bitum wereusedinthisstudy. Theanimals weredivided
into eight groups. Data on the group size, compounds
administered, routes of administration and doses ap-
plied are given in Table 1.
The animals were exposed to the metals for 2 weeks.
During exposure rats were keptin metabolic cages, one
animal per cage. Depending on the body weight, the
animals received solutions ofappropriate compounds in
volumes of0.38-0.62 cm2 intragastrically and 0.15-0.20
cm intraveneously per single dose. Selenium (Se) was
given intragastrically as water solution of sodium se-
lenite (Na2SeO3; POCh, Gliwice, Poland) every day at
single doses of 0.5 mg Se/kg.
Methylmercuric chloride (MeHg, K&K Laboratories
Inc., Plainview, NY, USA),labeledwith2mHg(CH32mHgCl,
Radiochemical Centre, Amsterdam, Bucks, England) of
specific activity 51.8 ,uCi/mg was given every other day
intragastrically in 0.1% sodium carbonate (Na2CO3;
POCh, Gliwice, Poland) or intraveneously in 0.9%
sodium chloride (NaCl, POCh, Gliwice, Poland).
Total excretion of mercury in feces and urine was
monitored for each animal daily. At 24 hr after the last
administration of methylmercury, rats were sacrificed
under ether narcosis by heart puncture, and individual
organs and tissues were isolated.
Mercury was determined directly in urine, feces, and
tissues after grinding or homogenization and suspend-
ing in starch, by -y-counting in an USB-2 scintillation
counter with a NaI/TI crystal. The counting time was
100 sec; the accuracy of counting was ± 10%.
Perfused liver and kidneys were fractionated by the
method described elsewhere (53) following the proce-
dures ofShibko et al. (54) and Lucierand McDaniel (55).
In kidney and liver homogenates and in successive su-
pernatants 203Hg was estimated by a radiochemical
method and protein concentration was measured (56).
Separation ofmercury-bindingproteins in the soluble
fraction of the kidneys and liver was performed by gel
filtration on Sephadex G-75(2.5 60 cm). The columns
were eluted withformatebuffer, pH8.0; 3-cm3 fractions
were collected at a rate of 10 cm/hr. The columns were
calibrated with: Dextran Blue (molecular weight of
2,000,000; Pharmacia, Sweden) cytochrome C (molec-
ular weight of 12,700; Serva, West Germany) and po-
tassium chromate (molecular weight of 194; POCh,
Gliwice, Poland). Mercury was assayed radiochemically
in column eluates and protein concentration was mon-
itored by measurements of absorbance at 280 and 250
nmin aVSU-2P spectrophotometer. Alldeterminations
were made separately for each animal.
Results
During the exposure, rats exposed to the lower dose
of methyl mercuric chloride (0.25 mg Hg/kg) excreted
about 62 ,ug Hg afterintragastric administration (group
I, Fig. 1), and about 50 pug Hg after intravenous injec-
tion (group II, Fig. 2) which amounted to about 20%
and 15%, respectively, of the cumulative dose of this
metal.
Rats exposed to the higher dose of methylmercury
(2.5 mg Hg/kg) excreted about 250 ,ug 203Hg, i.e., about
8% of the total metal administered, irrespective of the
route ofadministration, i.e., intragastric (group III) or
intravenous (group IV) (Figs. 3 and 4 and Table 2).
Sodium selenite administered both at an equimolar
dose with respect to mercury (groups IIIa and IVa)
(Figs. 3 and 4) and at a tenfold excess (groups Ia and
Ha) (Figs. 1 and 2) had little effect on the amount of
mercury excreted, irrespective of the route of admin-
istration of methylmercury. A tendency for decreased
mercury excretion was observed only with the tenfold
selenium excess. This effect was observed both in the
daily and cumulative excretion of 203Hg in urine and
feces.
The whole-body retention of 203Hg was about 78%
after a dose of 0.25 mg Hg/kg and about 70% after a
dose of2.5 mg Hg/kg(Table 2), irrespective ofthe route
of administration of methylmercury.
Table 1. Characteristics of experimental animal groups.
Compounds Dose of mercury, Route of Hg:Se molar
Group Number of animals administered mg Hg/kg administration of Hg ratio
I 6 MeHg 0.25 Intragastric
Ia 5 MeHg + Se 0.25 " 1:10
II 4 MeHg 0.25 Intravenous
IIa 5 MeHg + Se 0.25 " 1:10
III 5 MeHg 2.5 Intragastric
IIIa 5 MeHg + Se 2.5 " 1:1
IV 5 MeHg 2.5 Intravenous
IVa 5 MeHg + Se 2.5 " 1:1
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FIGURE 1. Cumulative (1) and daily (2) excretion of Me203Hg in urine and feces during 2-week intragastric exposure of rats to Me2'HgCl +
Se: (0) group I, 0.25 mg/Hg/kg; (x) group Ia, 0.25 mg Hg/kg +Se. Bars represent range from five animals.
The concentrations of mercury in tissues of rats ex-
posed intragastrically (group I) or intraveneously (group
II) to the lower dose of methylmercury (0.25 mg Hg/
kg) are shown in Table 3. For both routes of exposure,
the lowest concentration (1-3 ,ug Hg/g tissue) were found
in the brain, lungs, heart, liver, intestines, muscles,
bones, and skin. Mercury concentrations in the spleen
and blood and kidneys were 7 and 10 ,ug Hg/g tissue,
respectively.
A tenfold higher dose ofmethylmercury (2.5 mg Hg/
kg) supplied either intragastrically (group III) or in-
traveneously (group IV) resulted in a proportional ten-
fold increase in the concentration of203Hg in respective
tissues (Table 4).
Sodium selenite supplied at a tenfold excess with re-
spect to mercury given both intragastrically (group Ia)
and intraveneously (group Ha) elevated the concentra-
tion of 203Hg in the brain about twofold and decreased
it in the blood and kidneys (Table 3).
An equimolar dose of selenium with respect to mer-
cury had the greatest effect on the concentration of
203Hg in the brain ofrats, increasing it as in the case of
selenium excess (Table 4).
Due to the similarity of results for both routes of
administration of methylmercury, concentrations of
203Hg in organelles of the liver and kidneys expressed
per milligram protein are shownjointly in Tables 5 and
6 without indicating the type of exposure.
In animals exposed to the low dose ofmethylmercury
(0.25 mg Hg/kg) the concentrations of 203Hg in subcel-
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FIGURE 2. Cumulative (1) and daily (2) excretion of Me'3Hg in urine and feces during 2-week intravenous exposure of rats to Me2"Hg ±
Se: (A) group II, 0.25 mg Hg/kg; (x) group IIa, 0.25 mg Hg/kg + Se. Bars represent range from five animals.
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FIGURE 3. Cumulative (1) and daily (2) excretion of Me2O3Hg in urine and feces during 2-week intragastric exposure of rats to Me2"HgCl ±
Se: (C) group III, 2.5 mg Hg/kg; (x) group IIIa, 2.5 mg Hg/kg + Se. Bars represent range from five animals.
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FIGURE 4. Cumulative (1) and daily (2) excretion ofMe'3Hg in urine and feces during 2-week intravenous exposure of rats to Me2"HgCl +
Se: (A) group IV, 2.5 mg Hg/kg (x) group IVa, 2.5 mg Hg/kg + Se. Bars represent range from five animals.
Table 2. Whole body retention (mean and range) and whole body
to whole blood content of Me203 Hg ratio after 2 week
exposure of rats to methylmercuric chloride with or without
sodium selenite.
Whole-body Whole body
Group Treatment retention, %a Whole blood
I 0.25 mg Hg/kg, PO 77.3 5.5
72.7-82.8
II 0.25 mg Hg/kg, IV 78.4 4.4
74.1-81.2
III 2.5mgHg/kg,DO 69.1 4.5
60.2-82.0
IV 2.5 mg Hg/kg, IV 70.4 4.2
66.3-75.8
Ia 0.25 mg Hg/kg, PO + Se 79.0 6.8
74.8-85.2
IIa 0.25 mg Hg/kg, IV + se 86.6 6.2
68.2-120.5
IIIa 2.5 mg Hg/kg, PO + Se 81.0 4.2
71.9-92.3
IVa 2.5 mg Hg/kg, IV + Se 77.2 5.3
63.9-102.3
aMean and range.
lular fractions ofthe liver ranged from 0.005 ,ug Hg/mg
protein in the mitochondrial fraction to 0.031 jig Hg/mg
protein in the soluble fraction.
After exposure to the higher level ofmethylmercury
(2.5 mg Hg/kg), the highest concentrations of 'Hg were
found in the light lysosomal and microsomal fractions.
Inthesolublefractionoftheliver, retainingthismetal
with the highest efficiency irrespective of the routeof
administration and dose of methylmercury, 203Hg was
bound almost completely by high molecular weight pro-
teins (Fig. 5) and the amount ofmetal bound to proteins
depended only on the concentration of "3Hg in the total
soluble fraction. Sodium selenite did not affectthe bind-
ingpattern ofmercurytoproteins ofthe solublefraction
ofthe liver.
The excess of selenium practically did not alter the
levelofmercury(permgprotein)insubcellularfractions
ofthe liver. The only exception was the soluble fraction
in which the concentration ofmercury decreased (Table
5).
Anequimolar dose ofseleniuminduced aconsiderable
dimunition ofthe level ofmercuryinthe lightlysosomal
fraction and a simultaneous increase of its level in the
remainingfractions. The highest elevation took place in
the microsomal fraction (Table 5).
In the kidneys of rats exposed to the lower dose of
methylmercury (0.25 mg Hg/kg) the concentration of
'Hg referred to the protein content (Table 6) was the
highest in the microsomal, soluble and membrane
fractions.
After application ofthe tenfold higher dose of meth-
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Table 3. Concentration of methylmercury in rat tissues after 2-week intragastric exposure to Me203HgCl with or without
sodium selenite (mean ± SD).
Me203Hg, pLg/g tissuea
Tissue
Liver
Kidneys
Spleen
Heart
Brain
Lung
Stomach
Intestines
Tail
Skin
Muscle and bone
Blood
Plasma
Group I,
0.25 mg Hg/kg
1.62 ± 0.44
8.02 ± 1.54
3.32 ± 1.43
2.19 ± 0.36
0.83 ± 0.29
2.30 ± 0.42
0.70 ± 0.18
1.04 ± 0.34
0.77 ± 0.06
1.10 ± 0.48
1.04 ± 0.08
6.93 ± 0.47
0.09 ± 0.03
Group Ia,
0.25 mg Hg/kg + Se
1.64 ± 0.26
4.41 ± 1.60t
3.66 ± 0.72
2.14 ± 0.59
1.59 ± 0.23t
2.01 ± 0.28
0.65 ± 0.42
0.90 ± 0.20
0.85 ± 0.33
1.15 ± 0.27
1.16 ± 0.06*
5.57 ± 0.29k
0.08 ± 0.02
Group III,
2.5 mg Hg/kg
16.39 ± 3.92
79.12 ± 7.98
45.70 ± 11.67
16.91 ± 1.54
8.38 ± 1.87
18.23 ± 1.94
8.91 ± 5.14
8.67 ± 2.75
6.95 ± 3.23
14.04 ± 5.10
7.93 ± 1.58
80.17 ± 10.90
0.96 ± 0.28
Group IIIa,
2.5 mg Hg/kg + Se
20.50 ± 5.63
67.69 ± 10.46*
39.64 ± 6.48
17.44 ± 3.68
15.59 ± 2.1it
19.37 ± 3.88
12.29 ± 6.63
8.38 ± 2.41
9.30 ± 1.27
12.66 ± 3.73
8.71 ± 1.53
76.18 ± 10.13
0.86 ± 0.14
aMean ± SD.
*Significantly different from group of rats receiving the same dose of MeHg without selenium, p < 0.05.
tSignificantly different from group of rats receiving the same dose of MeHg without selenium, p < 0.01.
Table 4. Concentration of methylmercury in rat tissues after 2-week intravenous exposure to Me203HgCl with or without
sodium selenite (mean ± SD).
Tissue
Liver
Kidneys
Spleen
Heart
Brain
Lung
Stomach
Intestines
Tail
Skin
Muscle and bone
Blood
Plasma
Group II,
0.25 mg Hg/kg
1.65 ± 0.04
10.67 ± 1.75
4.58 ± 0.84
1.99 ± 0.29
0.77 ± 0.14
1.91 ± 0.13
0.53 ± 0.19
0.85 ± 0.13
1.85 ± 0.58
0.78 ± 0.06
1.04 ± 0.02
7.27 ± 0.88
0.17 ± 0.06
Me"'Hg, ,ug/g tissue'
Group Ila, Group IV,
0.25 mg Hg/kg + Se 2.5 mg Hg/kg
1.77 t 0.26 15.13 t 2.09
4.56 1.lOt 68.52 t 10.71
4.05 t 1.64 30.98 t 12.38
1.90 t 0.46 14.78 t 4.08
1.56 t 0.28t 6.15 t 2.20
1.98 t 0.50 13.84 t 3.18
0.55 t 0.25 5.45 t 1.48
0.85 t 0.28 8.11 t 2.56
2.19 t 0.53 22.82 t 10.15
0.92 t 0.67 12.54 t 2.23
1.29 t 0.46 7.28 t 0.60
5.56 1.11* 69.32 t 9.19
0.11 t 0.04 0.64 t 0.13
Group IVa,
2.5 mg Hg/kg + Se
23.39 ± 6.83*
59.24 ± 10.13
41.53 ± 13.56
23.32 ± 6.19*
15.94 ± 4.31t
20.79 ± 5.07t
6.70 ± 2.00
8.61 ± 2.22
25.39 ± 10.42
9.12 ± 4.61
9.55 ± 2.85
63.38 ± 16.41
0.58 ± 0.19
aMean ± SD. *Significantly different from group of rats receiving the same dose of MeHg without selenium, p < 0.05.
tSignificantly different.
Table 5. Methylmercury in subcellular fractions of rat liver after 2-week exposure to Me2"3HgCl with or without
sodium selenite (mean ± SD).
Me203Hg, Rg/g tissuea
Subcellular Groups I and II, Groups Ia and Ila, Groups III and IV, Groups IIIa and IVa,
fractions 0.25 mg Hg/kg 0.25 mg Hg/kg + Se 2.5 mg Hg/kg 2.5 mg Hg/kg + Se
H 0.010 ± 0.002 0.010 ± 0.001 0.096 ± 0.022 0.162 ± 0.059*
Ms 0.006 ± 0.003 0.007 ± 0.002 0.084 ± 0.038 0.138 ± 0.076
N 0.005 ± 0.002 0.009 ± 0.005 0.074 ± 0.022 0.087 ± 0.020
M 0.005 ± 0.002 0.007 ± 0.004 0.062 ± 0.020 0.169 ± 0.136*
Lh 0.014 ± 0.008 0.010 ± 0.004 0.069 ± 0.034 0.123 ± 0.123
LI 0.012 ± 0.002 0.011 ± 0.005 0.590 ± 0.525 0.207 ± 0.084
P 0.020 ± 0.007 0.019 ± 0.014 0.264 ± 0.189 0.675 ± 0.421*
S 0.025 ± 0.007 0.016 ± 0.002 0.164 ± 0.039 0.259 ± 0.105-
aMean ± SD.
*Significantly different from group of rats receiving the same dose of MeHg without selenium, p < 0.05.
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Table 6. Methylmercury in subcellular fractions of rat kidneys after 2-week exposure to Me203HgCl with or without
sodium selenite (mean ± SD).
Me203Hg, pLg/g tissuea
Subeellular Groups I and II, Groups Ia and IIa, Groups III and IV, Groups IlIa and IVa,
fractions 0.25 mg Hg/kg 0.25 mg Hg/kg + Se 2.5 mg Hg/kg 2.5 mg Hg/kg + Se
H 0.068 ± 0.012 0.027 ± 0.007t 0.499 ± 0.054 0.402 ± 0.038t
Ms 0.096 ± 0.052 0.027 ± 0.008t 0.387 ± 0.138 0.375 ± 0.106
N 0.046 ± 0.018 0.021 ± 0.012t 0.481 ± 0.100 0.267 ± 0.067t
M 0.057 ± 0.032 0.022 ± 0.013* 0.438 ± 0.263 0.317 ± 0.034
Lh 0.048 ± 0.020 0.050 ± 0.028* 0.451 ± 0.230 0.543 ± 0.152
LI 0.059 ± 0.020 0.027 ± 0.013t 0.707 ± 0.183 0.237 ± 0.042+
P 0.122 ± 0.020 0.060 ± 0.036* 0.684 ± 0.305 0.804 ± 0.278
S 0.096 ± 0.033 0.039 ± 0.007t 0.703 ± 0.135 0.573 ± 0.064
aMean ± SD.
*Significantly different from group of rats receiving the same dose of MeHg without selenium, p < 0.05.
tSignificantly different from group of rats receiving the same dose of MeHg without selenium, p < 0.01.
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FIGURE 5. Separations of soluble fraction of rat liver after 2-week intragastric and intravenous exposure to Me3HgCl ± Se: (1) groups I
and II (0.25 mg Hg/kg); (2) groups Ia and IIa (0.25 mg Hg/kg + Se); (3) groups III and IV (2.5 mg Hg/kg); (4) groups IIIa and IVa (2.5
mg Hg/kg + Se). Sephadex G-75 column eluted with buffer as described in Methods section: (- ) A2.; (--) A20, (-),g 103Hg. Arrows
indicate the position of Dextran Blue, cytochrome C, and K2CrO4.
ylmercury the highest concentrations of mercury were
found in the soluble, light lysosomal and microsomal
fractions.
In the kidneys ofrats given 2.5 mg Hg/kgthe soluble
fraction had the highest contribution to the accumula-
tion of203Hg, as in the case ofthe lower dose (Table 6).
The excess of selenium with respect to mercury
(Groups Ia and Ha) which decreased the concentration
of mercury in the kidneys (Tables 3 and 4) resulted in
a simultaneous diminution ofthe concentration of 3Hg
(as referred to the protein) in all subcellular fractions.
The highest decrease took place in the membranes. The
only exception was the heavy lysosomal fraction in which
selenium induced an increase in the concentration of
mercury. On the other hand, an equimolar dose of se-
lenium does not elevate the concentrations of 203Hg in
the subcellular fractions of kidneys (Table 6).
The binding of 203Hg by proteins of the subcellular
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fractions ofrat kidneys was dependent only on the dose
of methylmercury and the presence of sodium selenite
and was independent of the route of administration of
methylmercuric chloride. The pattern ofbinding of 'Hg
to proteins of the soluble fraction of the kidneys as a
function ofthe dose ofmethylmercuric chloride and the
presence of selenium is shown in Figure 6.
In rats exposed to the low dose of methylmercuric
chloride (0.25 mg Hg/kg, groups I and II) mercury was
bound by proteins ofthe soluble fraction ofthe kidneys
eluted in three distinct peaks (Fig. 6). High molecular
weight proteins bound 35.6 and 40.7% of mercury, de-
pending on the molecular weight; protein of molecular
weight of about 10,000 (probably metallothioneinlike
proteins) linked about 20.4% of 03Hg accumulated in
this fraction in the kidneys.
In the case ofthe higherdose (2.5mgHg/kg) ofmeth-
ylmercuric chloride (groups III and IV) mercury was
bound inthe form oftwopeaks tohighmolecularweight
proteins and to low molecular weight proteins (metal-
lothionein), with 34.3, 44.5, and 18.8% ofthe total metal
contained in this fraction, respectively (Fig. 6).
Sodium selenite administered at atenfold excess with
respect to mercury (groups Ia and IIa) brought about
aconsiderable decreaseinthe amount ofmercurybound
tohigh molecularweight proteins and practically totally
1.0
displaced mercury from metallothioneinlike proteins
(Fig. 6). High molecular weight proteins ofthe soluble
fraction of kidneys of rats of these groups bound, de-
pending on the molecular weight, about 37.2 and 55.8%
of 203Hg retained in the fraction.
Discussion
Results presented in this paper may allow determi-
nation of the possibility of forecasting the methylmer-
cury concentration in rat tissues on the basis of
determination ofits concentration in blood, and the ef-
fect of the presence of sodium selenite on such
estimations.
In the study, two different routes of administration
and two significantly different doses ofmethylmercury
(0.25 and 2.5mgHg/kg) were employed. This permitted
us to obtain different mercury:selenium ratios at a con-
stant dose of selenium (Table 1).
The studies performed indicate that, irrespective of
the dose and route ofadministration, the same percent
ofthe cumulative dose ofmethylmercury was excreted
in urine and feces (Figs. 1-4) and probablywith expired
air (1,14). As aresult, the percentwhole-bodyretention
ofmethylmercury after repeated exposure was similar
inallcasesandamountedtoabout70% ofthecumulative
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FIGURE 6. Separations of soluble fraction of rat kidneys after 2-week intragastric and intravenous exposure to Me2'3HgCl ± Se: (1) groups
I and II (0.25 mg Hg/kg); (2) groups Ia and IIa (0.25 mg Hg/kg + Se); (3) groups III and IV (2.5 mg Hg/kg); (4) groups IIIa and IVa (2.5
mg Hg/kg + Se). Sephadex G-75 column eluted with buffer as described in Methods section: ( ) A280; (--) A250; (-),ug 203Hg. Arrows
indicate the position of Dextran Blue, cytochrome c and K2CrO4.
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Table 7. Tissue Hg to blood Hg concentration ratio in rats after administration of methylmercuric compounds.
Brain Liver Kidney
Ireatment Dose pattern Blood Blood Blood Reference
7 x 0.25 mg Hg/kg, PO Repeated 0.12 0.23 1.17 Table 3
7 x 0.25 mg Hg/kg, IV Repeated 0.11 0.23 1.46 Table 4
7 x 2.5 mg Hg/kg, PO Repeated 0.09 0.18 1.01 Table 3
7 x 2.5 mg Hg/kg, IV Repeated 0.09 0.22 1.01 Table 4
10 x 1.0 mg Hg/kg, SC Repeated 0.14 0.29 0.86 (57)
9 x 13 ,ug Hg/rat, PO Repeated 0.07 0.28 1.12 (19)
9 x 1 ,ug Hg/rat, PO Repeated 0.08 0.29 1.25 (19)
0.84 mg/kg or 3.34 mg/kg, PO Repeated 0.06 0.27 1.07 (58)
100 pg Hg/rat, IV Single 0.17 0.27 0.71 (59)
34 mg Hg/kg, PO Single 0.07 0.26 0.53 (60)
116 ,ug Hg/rat, IV Single 0.18 0.23 1.14 (61)
dose. Upon termination of the exposure, the ratio of
the whole-body content ofmethylmercury to its content
in the blood was also almost independent of the dose
and route of administration and close to 5 (Table 2).
Our finding that in repeated exposure to methylmer-
cury its concentrations in individual tissues increased
approximately proportionally to the administered dose
(Tables 3 and 4) seems noteworthy. Owing to this phe-
nomenon, values of the methylmercury concentration
ratios tissue:blood were very similar ifnot identical for
both routes ofadministration and both doses, especially
in the case of such vital organs as brain, liver, and
kidneys (Table 7). This observation may allow in the
future for an estimation of methylmercury concentra-
tion in the tissues on the basis of its concentration in
the blood, especially when using similar conditions of
exposure for different purposes. Very similar values of
these ratios can be derived from data of other authors
(19,57,58) who also employed repeated exposure and,
like us, determined methylmercury concentrationintis-
sues and in blood soon (usually 24 hr) after termination
of the exposure (Table 7). Our calculations show that
values ofthoseratios are similaralsoaftersingleadmin-
istration ofmethylmercury (Table 7) ifmethylmercury
concentrations in blood and tissues in short times after
exposure are considered (59-61).
The presence ofselenium, though increasingthe whole-
body retention of methylmercury only slightly (Table
2) changed its levels in individual tissues significantly,
especially in the kidneys and brain, irrespective of the
dose and route ofadministration ofthe latter (Tables 3
and 4). This is reflected by significantly altered numer-
ical values of the tissue: blood methylmercury concen-
tration ratios (Table 8). Therefore, an estimate of the
tissues concentrations of methylmercury in the rat on
the basis ofits blood concentration maybe charged with
a large error in the presence of selenium. This refers
especially to the brain and kidneys, where the increase
and decrease, respectively, of this ratio is dependent
on the molar concentrations of mercury and selenium.
Itresults from the available data that an increase in the
methylmercury concentration in the rat brain takes place
not only with an excess of selenium (Table 3) or equi-
molarconcentrations ofboth elements (Table 4) but also
Table 8. Tissue Hg to blood Hg concentration ratio in rats
after simultaneous methylmercury and selenium administration.
Brain Liver Kidney
Treatment Blood Blood Blood Reference
0.25 mg Hg/kg, PO + Se 0.29 0.29 0.78 Table 3
0.25 mg Hg/kg, IV + Se 0.28 0.32 0.82 Table 4
2.5 mg Hg/kg, PO + Se 0.20 0.27 0.89 Table 3
2.5 mg Hg/kg, IV + Se 0.26 0.37 0.95 Table 4
when the molar dose of selenium was lower than the
molar dose of methylmercury (expressed as metalic
mercury). This effect was observed forboth single (50,51)
and repeated administration of methylmercury. How-
ever the mechanism involved remains unknown.
Onthe otherhand, selenium affectsthe level ofmeth-
ylmercury in rat kidneys significantly, and in this case
a clearcut diminution of the methylmercury concentra-
tion is attained only when selenium excess with respect
tomercuryisemployed(Table3). Thiseffectisobserved
in all subcellular fractions of this organ; in the soluble
fraction, the decrease includes the amount of methyl-
mercury bound to both high molecular weight and low
molecularweight protein fractions (Fig. 6). As aresult,
the kidneys:blood methylmercury concentration ratio is
decreased, especially for selenium excess (Table 8).
Numerous studies indicate that the interaction effect
of selenium and inorganic mercury is different and is
characterized by a clear-cut translocation of mercury
from low molecular to high molecular weight kidney
proteins (24,26,27,64) already at equimolar concentra-
tions of mercury and selenium (27). This phenomenon
is accompanied by about a fivefold diminution of mer-
cury concentration in the kidneys and inhibition of me-
tallothionein biosynthesis (26,27,64-66). Simultaneously
a distinct, about fourfold increase of the level of this
metal is observed, especially in the mitochondrial and
nuclear fractions (26) and concentration of mercury in
thebloodincreasesconsiderably(25,27,67). Such effects
are not observed in methylmercury-selenium interac-
tion. In this case no increase but rather a decrease in
the methylmercury concentration is found in the blood,
regardless ofwhether selenium was administered at an
equimolar dose (Table4) orin slight(65) orconsiderable
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(Table 3) excess. Usually it is accompanied by only a
small increase of the methylmercury concentration in
the liver (Tables 3 and 4) (65). The binding pattern of
Me203Hgtoproteins ofthe soluble fraction ofthekidneys
(Fig. 6) points to a possible participation ofmetallothi-
onein-like proteins in this process (15,68). That is prob-
ably due to the higher efficiency of biotransformation
of methylmercury to inorganic mercury in rat kidneys
as compared with liver (58,65,69,70); this process seems
to be strictly dependent on the dose of methylmercury
which has been taken into account in ourfurther studies
(71).
This work was performed within the framework ofProject MZIX,
Occupational Medicine, of the Ministry of Health, Polish People's
Republic.
We wish to thank Mrs. Honorata Debicka for excellent technical
assitance and for her help in the preparation of the figures.
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